Cardiometabolic syndrome comprises some of the most prevalent chronic illnesses plaguing men over 35 years old and the incidence rates are increasing in the developed world. It is imperative that we identify and mitigate the root cause drivers of cardiometabolic diseases and recent discoveries, from human microbiome studies, suggests that the microbiome may play a causal role in the onset and progression of numerous conditions under this umbrella. If the microbiome is a key driver, it signifies that an ecological problem is at the root and that the ecosystem could be modulated to dramatically reduce risk.

This lecture will outline the role of the microbiome in the onset and progression of cardiometabolic syndrome and low testosterone in men and will discuss mitigating strategies that can easily be incorporated into practice.